THOMAS ROBINSON: Open Payments
NPI 1669578779 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,356 in 74 payments from 15 companies in 2025. Trend: 2023 $1,514 · 2024 $1,737 · 2025 $1,356
Food & beverage: $1,356
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $481 |
| Janssen Biotech, Inc. | 11 | $208 |
| Madrigal Pharmaceuticals | 2 | $146 |
| GENZYME CORPORATION | 6 | $126 |
| PFIZER INC. | 5 | $73 |
| Phathom Pharmaceuticals, Inc. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| Ardelyx, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Celltrion USA Inc. | 1 | $26 |
Products named: TREMFYA, LINZESS, SKYRIZI, REZDIFFRA, DUPIXENT, RINVOQ, VOQUEZNA, XIFAXAN.
Industry payments across LA — which companies pay providers there.
